Resources

TechBio's 2024 breakthroughs proved it’s not just innovating—it’s transforming healthcare, with the UK leading the charge into a future where biology, tech, and data redefine possibilities.

New legislation was laid in Parliament last Thursday to modernise the regulation of clinical trials in the UK.

As 2024 comes to a close, we’re proud to reflect on a year of championing the life sciences sector, from driving impactful policy changes to fostering connections across the UK and beyond. Dive into our key achievements, events, and milestones that shaped the year and set the stage for an exciting 2025.

Today, deepmirror has raised $2.4 million to simplify the adoption of AI for molecule design and enable every company to get drugs to patients faster with their accessible AI-powered platform.

The Innovation Ecosystem Programme, an 18-month-long NHS England project, which the BIA have been involved in throughout, describes how the UK can lead the way globally in health gains and life sciences powered growth. Its final report was published last week.

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney disease (DKD) patients.

New data shows investing in life sciences produces great returns, London Life Sciences Week and #bioProcessUK are nearly here.

Attending the BIA’s TechBio UK conference this year offered an incredible opportunity to witness the ingenuity and innovation driving the future of life sciences.

Read today's blog to learn about our latest reports, upcoming events and our CEO's thoughts on the upcoming budget.

The UK is a global leader in TechBio, drawing substantial investments and nurturing a vibrant ecosystem of talent and businesses, reveals a report launched today by the BIA.

Today marks a pivotal moment for our Association as a key strategic objective has been realised: the new government has placed growth at the centre of its agenda, with life sciences positioned as a cornerstone of that plan.

Steve Bates OBE, CEO of the BIA, responded to the announcement of a new Regulatory Innovation Office.

The government's plan to put life sciences up in lights this Sunday ahead of the International investment Summit was somewhat overtaken by the news of the reorganisation of Keir Starmer's Number 10 team which dominated headlines. Nevertheless, it's been a busy week of announcements affecting our sector.

The BIA’s policy and public affairs team attended the conferences of the three major UK parties this year. This is a key point in the political calendar and allows us to highlight the sector through fringe events, meet policymakers, and get a sense of the political environment.

In this blog, the BIA's Senior Policy and Public Affairs Manager, Dr Emma Lawrence, discusses the life science implications of Lord Darzi's review.

In this blog, Albert Maguire-King, Media and Communications Executive at the BIA, discusses the recent Techbio Boost event hosted by KQ Labs and the BIA, highlighting the programme's role in supporting the growth of London-based techbio seed and pre-series A companies.